months, and ACV, 400 mg x 1/10-12 months). Patients with recurrences on steps two and three received an alternative dose of ACV, 200 mg x 3. Otherwise patients entered the previous dose-step. Five Results Twenty patients, 16 males and four females were enrolled in the study. Two male patients stopped before completing the whole study period. One patient left the study at month 10 because his job took him abroad. The other patient left the study at month 9, because ofparticipation in another study involving potential immunomodulatory effects. Data from both patients are included in the study.
The median duration of recurrent herpes genitaliswas 5 years (range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] , and the median number of attacks the previous year was 16 (range 8-24). Eight patients (40%/) had herpes at two or more sites and 7 (370%) had extragenital herpes. Seven patients (37%) had tried other antiviral treatment, and eight (40%) had tried acyclovir systematically before. None had used acyclovir locally or systemically the previous 8 weeks. Table 1 shows the number of patients with recurrences and abortive lesions in the four plus one treatment periods. One of twenty patients (5 %) had recurrences in the first period, one of twenty (50) in the second, six ofnineteen (32o%) in the third and two of eleven (18%) in the fourth 3 months period. Four (20%) of the patients had neither recurrent nor abortive lesions in the whole study period. In the first 3 months period 5 abortive lesions developed, the number decreased following continuous treatment, but rose to 36% in the low dose period (400 mg x 1) indicating break through lesions. None of the patients put back on 200 mg x 3 daily had recurrences or abortive lesions. Table 2 shows inhibition of HSV in 18 patients treated with acyclovir. All virus typed was classified as HSV-2. Sensitivity testing of HSV isolates from 17 patients before treatment showed full sensitivity towards acyclovir. During treatment 15 virus isolation attempts turned out negative. Two virus isolate during treatment were positive for HSV, and both Table 1 Number ofpatients with recurrences and abortive lesions during dose-titration with oral acyclovir Long-term suppression of severe recurrent genital herpes simplex infections with oral acyclovir: a dose-titration study 
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